Pathstone Family Office’s ResMed RMD Stock Holding History

Pathstone Family Office’s Portfolio RMD Stock Details RMD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$988K	Buy
2023 Q2	$1.11M	Buy
2023 Q1	$611K	Sell
2022 Q4	$3.03M	Buy
2022 Q3	$3.06M	Buy
2022 Q2	$266K	Buy
2022 Q1	$490K	Buy
2021 Q1	–	Sell
2020 Q4	$53K	Buy
2018 Q2	–	Sell
2018 Q1	$2K	Buy